LE, K., JR, S., MP, W., ML, H., T, S., A, G., . . . MA, W. (2024). Adaptation of an rVSV Ebola vaccine purification process for rapid development of a viral vaccine candidate for SARS-CoV-2. Biotechnology journal, 19(1), e2300041. https://doi.org/10.1002/biot.202300041
Chicago Style (17th ed.) CitationLE, Kuczynski, Shallow JR, Watson MP, Homsy ML, Svab T, Gruber A, Rustandi RR, Hu J, and Winters MA. "Adaptation of an RVSV Ebola Vaccine Purification Process for Rapid Development of a Viral Vaccine Candidate for SARS-CoV-2." Biotechnology Journal 19, no. 1 (2024): e2300041. https://doi.org/10.1002/biot.202300041.
MLA (9th ed.) CitationLE, Kuczynski, et al. "Adaptation of an RVSV Ebola Vaccine Purification Process for Rapid Development of a Viral Vaccine Candidate for SARS-CoV-2." Biotechnology Journal, vol. 19, no. 1, 2024, p. e2300041, https://doi.org/10.1002/biot.202300041.